FeesSafety
Pluang+

NRx Pharmaceuticals launches FDA-approved preservative-free ketamine, marking its shift to commercial stage.

Company Fundamentals
17 Nov 2026, 14:18 WIB
GlobeNewsWire
View Source
Bullish
NRx Pharmaceuticals launches FDA-approved preservative-free ketamine, marking its shift to commercial stage.

NRx Pharmaceuticals received FDA approval for its first drug, preservative-free ketamine, ahead of schedule and began commercial sales with a 17-person sales team targeting hospitals. The company expects the U.S. market for this sterile injectable ketamine to be around $400 million, growing 15% annually, and plans to expand its sterile product offerings in 2027. Collaborations with Yale support accelerated approval of its next drug, NRX-100, while a new product, NRX-200, is in development for subcutaneous delivery. Financially, NRx reported a net loss of $2.2 million for Q3 2026 but ended the quarter with $19.8 million in cash, positioning itself for growth and profitability in 2027.

NRx Pharmaceuticals' third quarter 2026 financial results and corporate update provide context for readers. As of Nov 17, 2026 18:51 WIB, among 150 priced Health-sector US stocks tradable on Pluang, 51 rose and 91 fell. Notable movers include TNGX at USD 25.18 with a 1-day change of +4.18%, NUWE at USD 4.44 down 3.90%, and HUM at USD 447.60 down 2.93% but with Pluang order activity showing 0% Sell / 100% Buy, highlighting strong buying interest in HUM.

More News

Adagene and City of Hope launch Phase 1 trial for new colorectal cancer combo therapy.

Adagene and City of Hope launch Phase 1 trial for new colorectal cancer combo therapy.

Adagene Inc. and City of Hope have started a Phase 1 clinical trial testing a new combination therapy for metastatic colorectal cancer patients resistant to standard treatments. The trial evaluates two experimental drugs, ivonescimab and muzastotug (...

Others
Bullish
58 minutes ago
Provident Bank appoints three leaders to boost commercial banking growth and services.

Provident Bank appoints three leaders to boost commercial banking growth and services.

Provident Bank announced three key leadership appointments to strengthen its Commercial Banking division. Edward Galan will lead Middle Market Lending, Dawn Scocco will manage portfolio and credit risk, and John Maio will head Treasury Management Ser...

Market News
Bullish
58 minutes ago
RoyaLand launches its first mobile game Palazzo Chronicles: Match 3 on Google Play.

RoyaLand launches its first mobile game Palazzo Chronicles: Match 3 on Google Play.

RoyaLand Company Ltd. has released its first mobile game, Palazzo Chronicles: Match 3, on the Google Play Store. The free-to-play match-3 puzzle game features over 270 levels where players restore a royal palace set in Risorgimento Italy. This launch...

Others
Bullish
58 minutes ago
Atiq Khan joins Dune as Director of Engineering to lead real-time onchain market data development.

Atiq Khan joins Dune as Director of Engineering to lead real-time onchain market data development.

Atiq Khan, with over 25 years in financial technology including roles at Goldman Sachs and Coinbase, has joined Dune as Director of Engineering. He will lead the engineering efforts behind Dune Market Data Feeds, which provide real-time trade and liq...

Others
Bullish
58 minutes ago
BlackRock increases voting rights in ICG PLC to 5.16% as of November 13, 2026

BlackRock increases voting rights in ICG PLC to 5.16% as of November 13, 2026

BlackRock, Inc. has increased its total voting rights in ICG PLC to 5.16% as of November 13, 2026, up from 5.17% previously reported. This includes 5.08% voting rights attached to shares and 0.08% through financial instruments. The notification was o...

Market News
Neutral
58 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App